Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00806520 · ClinicalTrials.gov registry record
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 16
- Enrollment target
NCT00806520 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 16 participants.
The verdict
NCT00806520 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Obtain Continuous Glucose Monitoring (CGM) data from individuals taking exenatide LAR, sitagliptin, or pioglitazone. The CGM measurements collected will help determine the characteristics of glucose control prior to treatment and during treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00806520
The ClinicalTrials.gov registry entry for NCT00806520 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00806520 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00806520 about?
NCT00806520 is a clinical study titled "Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control". Obtain Continuous Glucose Monitoring (CGM) data from individuals taking exenatide LAR, sitagliptin, or pioglitazone. The CGM measurements collected will help determine the characteristics of glucose control prior to treatment and during treatment.
What is the current status of trial NCT00806520?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2008-04. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT00806520?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.